SOMATROGON-GHLA

SOMATROGON-GHLA was reported 1247 times

SOMATROGON-GHLA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AIDS RELATED COMPLEX 1 0.0833
1 PATIENT-DEVICE INTERACTION ISSUE 4 0.0816
2 GREY MATTER HETEROTOPIA 1 0.0769
3 PITUITARY STALK INTERRUPTION SYNDROME 1 0.0667
4 PATIENT-DEVICE INCOMPATIBILITY 33 0.0483
5 ACRAL OVERGROWTH 1 0.0385
6 NAEVUS HAEMORRHAGE 1 0.0278
7 EPIPHYSIOLYSIS 5 0.0201
8 URETHRAL OPERATION 1 0.0182
9 FOCAL PERITONITIS 1 0.0161
10 SEPTO-OPTIC DYSPLASIA 1 0.0152
11 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 1 0.0145
12 PUNCTURE SITE HAEMORRHAGE 7 0.0099
13 INSULIN RESISTANT DIABETES 1 0.0085
14 ADMINISTRATION SITE RASH 1 0.0078
15 INSULIN-LIKE GROWTH FACTOR DECREASED 4 0.0076
16 PINEAL GLAND CYST 1 0.0071
17 LACK OF INJECTION SITE ROTATION 12 0.0069
18 MEDICAL DEVICE SITE DISCHARGE 1 0.0065
19 LIPODYSTROPHY ACQUIRED 13 0.0061
20 ENLARGED CLITORIS 1 0.0061
21 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 1 0.0057
22 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
23 CARDIAC NEOPLASM UNSPECIFIED 1 0.0050
24 NEUROBLASTOMA RECURRENT 1 0.0049
25 ADENOTONSILLECTOMY 1 0.0040
26 SHORT STATURE 1 0.0038
27 EXPOSURE TO CONTAMINATED DEVICE 1 0.0038
28 HYPERTROPHY 2 0.0037
29 MORAXELLA INFECTION 1 0.0036
30 SYRINGOMYELIA 1 0.0036
31 BLOOD GROWTH HORMONE INCREASED 2 0.0036
32 KIDNEY SMALL 1 0.0034
33 LACK OF ADMINISTRATION SITE ROTATION 1 0.0033
34 HYPERINSULINAEMIA 1 0.0033
35 CORTISOL INCREASED 2 0.0032
36 INJECTION SITE HYPERTROPHY 1 0.0031
37 INJECTION SITE ATROPHY 5 0.0030
38 GROWTH FAILURE 1 0.0029
39 DEVICE MATERIAL ISSUE 6 0.0029
40 MUSCLE HYPERTROPHY 1 0.0028
41 SPINAL CORD OEDEMA 1 0.0027
42 DEVICE MECHANICAL ISSUE 36 0.0026
43 INJECTION SITE PAIN 805 0.0026
44 AMYOTROPHY 1 0.0026
45 PRODUCT KNOWLEDGE DEFICIT 2 0.0026
46 EXPOSURE VIA EYE CONTACT 1 0.0024
47 PRODUCT COMMUNICATION ISSUE 19 0.0022
48 NEUROLOGICAL EXAMINATION ABNORMAL 1 0.0021
49 INSULIN-LIKE GROWTH FACTOR INCREASED 3 0.0021
50 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
51 PROTEIN-LOSING GASTROENTEROPATHY 1 0.0020
52 METASTASES TO BONE MARROW 1 0.0020
53 PRODUCT CONTAMINATION 7 0.0020
54 DEVICE USE CONFUSION 1 0.0019
55 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
56 INJECTION SITE DISCHARGE 10 0.0019
57 BLOOD IMMUNOGLOBULIN A INCREASED 1 0.0019
58 EPHELIDES 1 0.0019
59 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
60 BLOOD INSULIN INCREASED 1 0.0018
61 INCORRECT DOSE ADMINISTERED BY DEVICE 47 0.0018
62 HEAD BANGING 1 0.0018
63 PRECOCIOUS PUBERTY 1 0.0018
64 LARYNGEAL STENOSIS 1 0.0017
65 PNEUMOCOCCAL INFECTION 1 0.0017
66 FEAR OF INJECTION 12 0.0017
67 MEAN PLATELET VOLUME INCREASED 1 0.0017
68 MEDICAL DEVICE SITE INFECTION 1 0.0016
69 RECTAL FISSURE 1 0.0016
70 EXTREMITY CONTRACTURE 1 0.0016
71 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
72 INJECTION SITE EXFOLIATION 1 0.0015
73 MAMMOGRAM ABNORMAL 1 0.0015
74 THYROXINE INCREASED 1 0.0014
75 MONOCYTE PERCENTAGE INCREASED 1 0.0014
76 INJECTION SITE HYPOAESTHESIA 2 0.0014
77 BITE 1 0.0014
78 SPONTANEOUS HAEMATOMA 1 0.0013
79 INJECTION SITE DISCOMFORT 14 0.0013
80 LIMB ASYMMETRY 1 0.0013
81 CRITICAL ILLNESS 1 0.0013
82 PNEUMONIA MYCOPLASMAL 1 0.0013
83 EXCESSIVE GRANULATION TISSUE 1 0.0012
84 HEAT EXHAUSTION 1 0.0012
85 NEEDLE ISSUE 36 0.0012
86 REACTION TO PRESERVATIVES 1 0.0012
87 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
88 DEVICE DELIVERY SYSTEM ISSUE 33 0.0012
89 CULTURE POSITIVE 1 0.0012
90 INFUSION SITE OEDEMA 1 0.0012
91 DEVICE PHYSICAL PROPERTY ISSUE 9 0.0012
92 DEVICE LOOSENING 1 0.0012
93 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
94 PAPILLOEDEMA 5 0.0011
95 LIPOATROPHY 1 0.0011
96 ARNOLD-CHIARI MALFORMATION 1 0.0010
97 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 49 0.0010
98 GROWTH RETARDATION 3 0.0010
99 POOR QUALITY DEVICE USED 10 0.0010
100 OPTIC NEUROPATHY 2 0.0009
101 KETOSIS 1 0.0009
102 PRODUCT NAME CONFUSION 1 0.0009
103 PRODUCT SELECTION ERROR 1 0.0009
104 INTRACRANIAL PRESSURE INCREASED 5 0.0009
105 HAEMOGLOBINURIA 1 0.0009
106 PHARYNGEAL INFLAMMATION 1 0.0008
107 INJECTION SITE INFLAMMATION 4 0.0008
108 RENAL ATROPHY 1 0.0008
109 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
110 SCREAMING 5 0.0008
111 INFUSION SITE IRRITATION 1 0.0008
112 ACROCHORDON 1 0.0008
113 INJECTION SITE MASS 27 0.0007
114 NASAL DISCHARGE DISCOLOURATION 1 0.0007
115 JOINT INSTABILITY 1 0.0007
116 VASCULAR INJURY 1 0.0007
117 INJURY ASSOCIATED WITH DEVICE 14 0.0007
118 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
119 NEGATIVE THOUGHTS 2 0.0007
120 PNEUMONIA PNEUMOCOCCAL 1 0.0007
121 INJECTION SITE PARAESTHESIA 1 0.0007
122 DEVICE LEAKAGE 28 0.0006
123 INJECTION SITE HYPERSENSITIVITY 2 0.0006
124 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
125 VEIN RUPTURE 1 0.0006
126 TONSILLAR HYPERTROPHY 1 0.0006
127 MILIARIA 1 0.0006
128 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
129 DEVICE DEFECTIVE 10 0.0006
130 HYPOPITUITARISM 1 0.0006
131 INFUSION SITE DISCHARGE 1 0.0006
132 DRUG DOSE OMISSION BY DEVICE 43 0.0005
133 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
134 BODY TEMPERATURE ABNORMAL 1 0.0005
135 CLAVICLE FRACTURE 2 0.0005
136 INJECTION SITE SWELLING 40 0.0005
137 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
138 EXPOSURE VIA SKIN CONTACT 13 0.0005
139 CRYING 18 0.0005
140 DEVICE CONNECTION ISSUE 1 0.0005
141 INFUSION SITE BRUISING 1 0.0005
142 MELANOCYTIC NAEVUS 2 0.0005
143 LIMB MASS 1 0.0005
144 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
145 BLOOD PROLACTIN INCREASED 2 0.0004
146 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
147 MYOPIA 1 0.0004
148 DIABETES INSIPIDUS 1 0.0004
149 WRONG DOSE 1 0.0004
150 GUILLAIN-BARRE SYNDROME 2 0.0004
151 BREATH ODOUR 1 0.0004
152 INFREQUENT BOWEL MOVEMENTS 1 0.0004
153 APPENDICITIS PERFORATED 1 0.0004
154 INJECTION SITE ERYTHEMA 48 0.0004
155 LIPOMA 1 0.0004
156 PRODUCT ODOUR ABNORMAL 4 0.0004
157 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
158 ABDOMINAL MASS 1 0.0004
159 AUTISM SPECTRUM DISORDER 2 0.0004
160 MACULE 1 0.0004
161 EOSINOPHIL COUNT INCREASED 3 0.0004
162 DEVICE OCCLUSION 5 0.0004
163 PERIORBITAL SWELLING 2 0.0004
164 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
165 INJECTION SITE SCAR 1 0.0004
166 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
167 PRODUCT PRESCRIBING ERROR 8 0.0003
168 MEDICAL DEVICE DISCOMFORT 1 0.0003
169 INJECTION SITE RASH 10 0.0003
170 PNEUMONIA VIRAL 1 0.0003
171 INJECTION SITE PRURITUS 21 0.0003
172 DEVICE DEPLOYMENT ISSUE 4 0.0003
173 INJECTION SITE INDURATION 4 0.0003
174 BREAST ENLARGEMENT 1 0.0003
175 DYSGRAPHIA 2 0.0003
176 SUSPECTED COVID-19 1 0.0003
177 APPETITE DISORDER 2 0.0003
178 DEVICE BREAKAGE 12 0.0003
179 HUNGER 4 0.0003
180 DEVICE USE ISSUE 5 0.0003
181 SCRATCH 3 0.0003
182 BONE DENSITY ABNORMAL 1 0.0003
183 INJECTION SITE HAEMORRHAGE 21 0.0003
184 GASTRIC INFECTION 1 0.0003
185 RHINOVIRUS INFECTION 1 0.0003
186 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
187 GALLBLADDER OPERATION 1 0.0002
188 GOITRE 1 0.0002
189 SUICIDAL BEHAVIOUR 1 0.0002
190 INJECTION SITE BRUISING 19 0.0002
191 FACIAL PARALYSIS 2 0.0002
192 DEVICE ISSUE 21 0.0002
193 TEARFULNESS 1 0.0002
194 DEVICE DIFFICULT TO USE 15 0.0002
195 RESPIRATORY RATE INCREASED 2 0.0002
196 SUSPECTED OFF LABEL USE 1 0.0002
197 VASCULAR DEVICE INFECTION 1 0.0002
198 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
199 INCREASED APPETITE 4 0.0002
200 ACCIDENTAL UNDERDOSE 3 0.0002
201 NASAL POLYPS 1 0.0002
202 DEVICE USE ERROR 7 0.0002
203 PETIT MAL EPILEPSY 1 0.0002
204 WEIGHT LOSS POOR 1 0.0002
205 PARTIAL SEIZURES 1 0.0002
206 INTESTINAL RESECTION 1 0.0002
207 STREPTOCOCCAL INFECTION 1 0.0002
208 HEART RATE ABNORMAL 1 0.0002
209 PRODUCT LEAKAGE 1 0.0002
210 STATUS EPILEPTICUS 2 0.0002
211 GASTROENTERITIS VIRAL 3 0.0002
212 TYPE 1 DIABETES MELLITUS 1 0.0002
213 INJECTION SITE VESICLES 1 0.0002
214 ADRENAL INSUFFICIENCY 2 0.0002
215 TENSION 1 0.0002
216 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
217 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
218 MENINGITIS 1 0.0001
219 WRONG PRODUCT ADMINISTERED 1 0.0001
220 MOOD ALTERED 4 0.0001
221 NEPHROTIC SYNDROME 1 0.0001
222 HAIR GROWTH ABNORMAL 1 0.0001
223 INJECTION SITE HAEMATOMA 2 0.0001
224 PRODUCT PRESCRIBING ISSUE 3 0.0001
225 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
226 MOUTH HAEMORRHAGE 1 0.0001
227 HYPERTHERMIA 1 0.0001
228 EPILEPSY 4 0.0001
229 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
230 ABNORMAL BEHAVIOUR 5 0.0001
231 HYPOGLYCAEMIA 6 0.0001
232 INJECTION SITE URTICARIA 3 0.0001
233 POLYURIA 1 0.0001
234 MUSCLE INJURY 1 0.0001
235 INCORRECT DOSE ADMINISTERED 27 0.0001
236 PSEUDOMONAS INFECTION 1 0.0001
237 SKIN HYPERPIGMENTATION 1 0.0001
238 INJECTION SITE REACTION 8 0.0001
239 PSYCHOLOGICAL TRAUMA 1 0.0001
240 PYELONEPHRITIS 1 0.0001
241 BLOOD CALCIUM INCREASED 1 0.0001
242 THIRST 2 0.0001
243 GASTROINTESTINAL INFECTION 1 0.0001
244 OROPHARYNGEAL DISCOMFORT 1 0.0001
245 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
246 ERYTHEMA MULTIFORME 1 0.0001
247 MIDDLE INSOMNIA 2 0.0001
248 APPENDICITIS 1 0.0001
249 LEUKAEMIA 1 0.0001
250 SEIZURE 12 0.0001
251 PHARYNGEAL SWELLING 1 0.0001
252 VITREOUS FLOATERS 1 0.0001
253 KNEE OPERATION 1 0.0001
254 HYPOTONIA 1 0.0001
255 INITIAL INSOMNIA 1 0.0001
256 EMOTIONAL DISORDER 3 0.0001
257 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
258 PETECHIAE 1 0.0001
259 VIRAL INFECTION 3 0.0001
260 SYNCOPE 9 0.0001
261 MALNUTRITION 1 0.0001
262 CHOLECYSTECTOMY 1 0.0001
263 DEVICE MALFUNCTION 6 0.0001
264 MYOCLONUS 1 0.0001
265 PANIC ATTACK 3 0.0001
266 INJECTION SITE DISCOLOURATION 1 0.0001
267 AGGRESSION 4 0.0001
268 DERMATITIS ALLERGIC 1 0.0001
269 MYDRIASIS 1 0.0001
270 INFUSION SITE PAIN 1 0.0001
271 DEAFNESS 2 0.0001
272 EAR INFECTION 2 0.0001
273 JOINT RANGE OF MOTION DECREASED 1 0.0001
274 IMPAIRED GASTRIC EMPTYING 1 0.0001
275 MASS 1 0.0001
276 PRODUCT DOSE OMISSION ISSUE 21 0.0001
277 BLOOD TEST ABNORMAL 1 0.0001
278 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
279 HYPERTHYROIDISM 1 0.0001
280 INTENTIONAL PRODUCT MISUSE 6 0.0001
281 UNDERDOSE 5 0.0001
282 NASAL CONGESTION 4 0.0001
283 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
284 INSURANCE ISSUE 1 0.0001
285 DEVICE RELATED INFECTION 1 0.0001
286 THYROID DISORDER 1 0.0001
287 CYANOSIS 1 0.0001
288 HEADACHE 38 0.0001
289 PHOTOSENSITIVITY REACTION 1 0.0001
290 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
291 FACE OEDEMA 1 0.0001
292 FLUID RETENTION 3 0.0001
293 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
294 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
295 WEIGHT INCREASED 13 0.0001
296 ORTHOSTATIC HYPOTENSION 1 0.0001
297 SYRINGE ISSUE 1 0.0001
298 EOSINOPHILIA 1 0.0001
299 DEPRESSED MOOD 3 0.0001
300 OEDEMA 3 0.0001
301 FRACTURE 1 0.0001
302 SLEEP APNOEA SYNDROME 1 0.0001
303 EAR PAIN 1 0.0001
304 SINUS DISORDER 1 0.0001
305 UPPER LIMB FRACTURE 1 0.0001
306 PRESCRIBED UNDERDOSE 1 0.0001
307 PRODUCT ADMINISTRATION ERROR 1 0.0000
308 EXTRA DOSE ADMINISTERED 2 0.0000
309 ANXIETY 14 0.0000
310 BLINDNESS 2 0.0000
311 INJECTION SITE WARMTH 1 0.0000
312 JOINT INJURY 1 0.0000
313 MENTAL DISORDER 2 0.0000
314 APPLICATION SITE PAIN 1 0.0000
315 NEOPLASM MALIGNANT 3 0.0000
316 INFLUENZA 5 0.0000
317 SNEEZING 1 0.0000
318 TINNITUS 2 0.0000
319 MUSCLE TWITCHING 1 0.0000
320 SWELLING 4 0.0000
321 MIGRAINE 4 0.0000
322 MENTAL IMPAIRMENT 1 0.0000
323 PRESYNCOPE 1 0.0000
324 AGITATION 3 0.0000
325 DYSGEUSIA 3 0.0000
326 PRODUCT COMPLAINT 1 0.0000
327 HAEMATEMESIS 1 0.0000
328 ILLNESS 4 0.0000
329 DIPLOPIA 1 0.0000
330 RESPIRATORY TRACT INFECTION 1 0.0000
331 VOMITING 18 0.0000
332 PYREXIA 13 0.0000
333 PALLOR 1 0.0000
334 TREATMENT NONCOMPLIANCE 2 0.0000
335 OFF LABEL USE 32 0.0000
336 SKIN LESION 1 0.0000
337 URTICARIA 6 0.0000
338 INTENTIONAL DOSE OMISSION 1 0.0000
339 ERYTHEMA 7 0.0000
340 PAIN IN EXTREMITY 10 0.0000
341 WHEEZING 2 0.0000
342 LACRIMATION INCREASED 1 0.0000
343 OEDEMA PERIPHERAL 4 0.0000
344 MOOD SWINGS 1 0.0000
345 HYPOTHYROIDISM 1 0.0000
346 RHINORRHOEA 2 0.0000
347 STAPHYLOCOCCAL INFECTION 1 0.0000
348 FUNGAL INFECTION 1 0.0000
349 SKIN DISORDER 1 0.0000
350 DRY SKIN 4 0.0000
351 GAIT INABILITY 1 0.0000
352 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
353 ANGER 1 0.0000
354 HAEMATURIA 1 0.0000
355 ABDOMINAL PAIN UPPER 6 0.0000
356 DELIRIUM 1 0.0000
357 HEART RATE DECREASED 1 0.0000
358 THERAPY INTERRUPTED 2 0.0000
359 ACCIDENTAL OVERDOSE 1 0.0000
360 BRONCHITIS 2 0.0000
361 EPISTAXIS 2 0.0000
362 HOT FLUSH 2 0.0000
363 ABDOMINAL PAIN 6 0.0000
364 DYSKINESIA 1 0.0000
365 NEUTROPHIL COUNT DECREASED 1 0.0000
366 INFLUENZA LIKE ILLNESS 2 0.0000
367 DIZZINESS 12 0.0000
368 SEPTIC SHOCK 1 0.0000
369 RASH 10 0.0000
370 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
371 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
372 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
373 PNEUMONIA 7 0.0000
374 OROPHARYNGEAL PAIN 2 0.0000
375 PAIN 13 0.0000
376 DYSPHAGIA 2 0.0000
377 DISEASE RECURRENCE 1 0.0000
378 COMA 1 0.0000
379 PRODUCTIVE COUGH 1 0.0000
380 RASH ERYTHEMATOUS 1 0.0000
381 FEELING ABNORMAL 5 0.0000
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
383 CONTUSION 2 0.0000
384 DRUG INTOLERANCE 2 0.0000
385 HEART RATE INCREASED 2 0.0000
386 DRY EYE 1 0.0000
387 LEUKOPENIA 1 0.0000
388 THERAPY CESSATION 1 0.0000
389 INFLAMMATION 1 0.0000
390 NERVOUSNESS 1 0.0000
391 PANCREATITIS 1 0.0000
392 RASH PRURITIC 1 0.0000
393 ANAPHYLACTIC REACTION 1 0.0000
394 NECK PAIN 1 0.0000
395 ASTHMA 2 0.0000
396 LETHARGY 1 0.0000
397 PRODUCT SUBSTITUTION ISSUE 1 0.0000
398 BONE PAIN 1 0.0000
399 DISEASE PROGRESSION 2 0.0000
400 IRRITABILITY 1 0.0000
401 VERTIGO 1 0.0000
402 DISCOMFORT 1 0.0000
403 FEELING HOT 1 0.0000
404 NASOPHARYNGITIS 3 0.0000
405 HYPERSENSITIVITY 3 0.0000
406 GAIT DISTURBANCE 3 0.0000
407 LOSS OF CONSCIOUSNESS 2 0.0000
408 HYPERHIDROSIS 2 0.0000
409 SWELLING FACE 1 0.0000
410 BLOOD CREATININE INCREASED 1 0.0000
411 NAUSEA 12 0.0000
412 INFUSION RELATED REACTION 1 0.0000
413 INSOMNIA 4 0.0000
414 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
415 VISION BLURRED 2 0.0000
416 ARTHRALGIA 6 0.0000
417 WEIGHT DECREASED 4 0.0000
418 COUGH 4 0.0000
419 SLEEP DISORDER 1 0.0000
420 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
421 MOBILITY DECREASED 1 0.0000
422 ACNE 1 0.0000
423 CONDITION AGGRAVATED 4 0.0000
424 PRURITUS 5 0.0000
425 ARTHRITIS 1 0.0000
426 DRUG INEFFECTIVE 16 0.0000
427 TREMOR 2 0.0000
428 RENAL IMPAIRMENT 1 0.0000
429 FATIGUE 9 0.0000
430 PRODUCT STORAGE ERROR 1 0.0000
431 MUSCULOSKELETAL STIFFNESS 1 0.0000
432 MALAISE 5 0.0000
433 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
434 GASTROINTESTINAL DISORDER 1 0.0000
435 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
436 NO ADVERSE EVENT 2 0.0000
437 SUICIDAL IDEATION 1 0.0000
438 CHEST PAIN 2 0.0000
439 PRODUCT USE ISSUE 2 0.0000
440 ASTHENIA 4 0.0000
441 SOMNOLENCE 2 0.0000
442 FLUSHING 1 0.0000
443 ABDOMINAL DISTENSION 1 0.0000
444 HAEMORRHAGE 1 0.0000
445 CONSTIPATION 2 0.0000
446 SEPSIS 1 0.0000
447 MUSCULAR WEAKNESS 1 0.0000
448 DEPRESSION 2 0.0000
449 DECREASED APPETITE 2 0.0000
450 BACK PAIN 2 0.0000
451 EMOTIONAL DISTRESS 1 0.0000
452 DIARRHOEA 5 0.0000
453 RENAL FAILURE 1 0.0000
454 DEHYDRATION 1 0.0000
455 NEUTROPENIA 1 0.0000
456 INFECTION 1 0.0000
457 DRUG INTERACTION 1 0.0000
458 ABDOMINAL DISCOMFORT 1 0.0000
459 MYALGIA 1 0.0000
460 URINARY TRACT INFECTION 1 0.0000
461 MYOCARDIAL INFARCTION 1 0.0000
462 COVID-19 1 0.0000
463 MUSCLE SPASMS 1 0.0000
464 BLOOD GLUCOSE INCREASED 1 0.0000
465 OVERDOSE 1 0.0000
466 DYSPNOEA 2 0.0000
467 DEATH 2 0.0000